Standard Chemical & Pharmaceutical Co. Ltd. - Taiwan
Figures in New Taiwan dollars.
2026 2025
Revenue NT$615,012,000 NT$563,676,000
Jan-Jun Revenue NT$3,524,488,000 NT$3,467,765,000
Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.
(END) Dow Jones Newswires
July 09, 2026 03:26 ET (07:26 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.